Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab) 2022-12-12 21:00
Asieris'Bladder Cancer Diagnostic Drug Hexvix® Completed Dosing of First Patient in Real-World Clinical Study 2022-12-12 20:59
JW Therapeutics Presents Latest Clinical Data on Carteyva® in Follicular Lymphoma and Mantle Cell Lymphoma at the 64th ASH Annual Meeting 2022-12-12 18:00
Asieris Enrolled First Patient for its Phase II Clinical Study of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer 2022-12-12 17:47
Alphamab Oncology Presented Clinical Data of KN026 Combined with Docetaxel in first-line treatment of HER2-positive recurrent/metastatic breast cancer at SABCS 2022 2022-12-12 15:51
Alphamab Oncology Presented Clinical Data of KN026 Combined with Docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer at SABCS 2022 2022-12-12 15:00
China further optimizes COVID-19 response with new measures 2022-12-12 11:38
Alphamab Oncology Presented Final Analysis of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at SABCS 2022 2022-12-12 10:33
Innovent Presents Phase 1b Clinical Data of IBI188 (Anti-CD47 Monoclonal Antibody) at the 2022 American Society of Hematology Annual Meeting 2022-12-11 08:00
Treadwell Therapeutics Announces A Presentation at the 2022 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor 2022-12-09 22:30
Innovent Presents Phase Ib Clinical Data of IBI939 (Anti-TIGIT Monoclonal Antibody) in Previously Untreated PD-L1-selected NSCLC at the 2022 European Society For Medical Oncology Immuno-Oncology Congress 2022-12-09 08:00
Innovent Presents Phase Ib Clinical Data Update of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 European Society For Medical Oncology Immuno-Oncology Congress 2022-12-09 08:00
SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France 2022-12-09 06:30
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA 2022-12-08 22:00
Createrna Announces Positive Top-Line Results from Phase 1 Clinical Trials of QR052107B Tablet in Healthy Volunteers 2022-12-08 14:29
Antengene Appoints Amily Zhang as its Chief Medical Officer 2022-12-08 08:30
Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by China NMPA 2022-12-07 18:10
Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood 2022-12-07 14:00
Apollo Proton Cancer Centre successfully performs Asia's 1st Brain Bypass Surgery on twin children with Moya Moya Disease 2022-12-07 13:17
Suvoda Launches eCOA-Specific Language and Design Toolkit as Solution Moves to Second Phase of Early Adopter Program 2022-12-07 08:00
1 96 97 98 99 100 375